/4BB.L
4BB.L Stock - 4basebio PLC
Healthcare|BiotechnologyLSE
$615.00-5.38%
$35.00 (-5.38%) • Dec 22
51
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.1
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.82
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $676.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4BB.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$608.85 – $621.15
TARGET (TP)$707.25
STOP LOSS$565.80
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.94
52W High$1300.00
52W Low$605.36
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $933,000 | $506,000 | $268,000 | $338,000 | $462,000 |
| Gross Profit | $630,000 | $340,000 | $239,000 | $269,000 | $274,000 |
| Gross Margin | 67.5% | 67.2% | 89.2% | 79.6% | 59.3% |
| Operating Income | $-12,042,000 | $-8,052,000 | $-5,840,000 | $-3,527,000 | $-622,000 |
| Net Income | $-12,333,000 | $-7,665,000 | $-5,150,000 | $-3,235,000 | $-719,000 |
| Net Margin | -1321.9% | -1514.8% | -1921.6% | -957.1% | -155.6% |
| EPS | $-0.94 | $-0.62 | $-0.42 | $-0.26 | $-0.06 |
Company Overview
4basebio PLC engages in the design, development, manufacturing, and supply of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company provides research kits, bulk enzymes, and other products, as well as licensing services; and AVV manufacturing services. It serves biotech, pharma, and contract development and manufacturing organization customers. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was incorporated in 2020 and is based in Cambridge, United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4BB.LBeat Rate
0%
Last 1 quarters
Avg Surprise
-3.1%
EPS vs Estimate
Beats / Misses
0/1
Last 12 quarters
Latest EPS
$-0.50
Q2 2025
EPS Surprise History
Q4 21
No data
Q3 22
No data
Q2 23
No data
Q3 23
-3.1%
$-0.29vs$-0.28
Q2 24
No data
Q3 24
No data
Q2 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 25, 2026 | — | — | — | — |
Q2 2025 | Jun 30, 2025 | — | $-0.50 | — | — |
Q2 2025 | May 27, 2025 | — | $-0.51 | — | — |
Q3 2024 | Sep 27, 2024 | — | $-0.45 | — | — |
Q2 2024 | May 16, 2024 | — | $-0.33 | — | — |
Q3 2023 | Sep 21, 2023 | $-0.28 | $-0.29 | -3.1% | ✗ MISS |
Q2 2023 | May 11, 2023 | — | $-0.22 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.20 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.13 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.13 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.03 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.03 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.02 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4BB.L
What is 4BB.L's current stock price?
4basebio PLC (4BB.L) is currently trading at $615.00 per share. The stock has moved -5.38% today.
What is the analyst price target for 4BB.L?
No analyst price targets are currently available for this stock.
What sector is 4basebio PLC in?
4basebio PLC operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the LSE exchange.
What is 4BB.L's market cap?
4basebio PLC has a market capitalization of $0.10 billion, making it a small-cap company.
Does 4BB.L pay dividends?
No, 4basebio PLC does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBVXP.L
Bioventix PLC
$1810.00
Mkt Cap: $9.5B
DXRX.L
Diaceutics PLC
$128.00
Mkt Cap: $10.8B
EKF.L
EKF Diagnostics Holdings plc
$25.30
Mkt Cap: $11.4B
FAB.L
Fusion Antibodies plc
$13.00
Mkt Cap: $1.5B
HEMO.L
Hemogenyx Pharmaceuticals Plc
$634.00
Mkt Cap: $3.8B
IMM.L
ImmuPharma plc
$5.30
Mkt Cap: $2.7B
OBI.L
Ondine Biomedical Inc.
$9.00
Mkt Cap: $3.9B
SAR.L
Sareum Holdings plc
$15.50
Mkt Cap: $2.1B
SBTX.L
SkinBioTherapeutics Plc
$13.25
Mkt Cap: $3.4B
SCLP.L
Scancell Holdings plc
$9.90
Mkt Cap: $10.3B
Explore stocks similar to 4BB.L for comparison